The data audit is a critical element in any quality assurance program and an area in which considerably more methods development is needed. To assist the QAU in organizing the requirements of the data audit for bioassay data and in developing a more rational and flexible sampling strategy, a decision tree has been designed.
INTRODUCTION
HE DATA AUDIT IS A CRITICAL ELEMENT in any quality assurance program and an area in T which considerably more methods development is needed. Performing a data audit for bioresearch studies is particularly challenging. especially with the advent of computerized data acquisition systems. The general rule of thumb for quality assurance professionals monitoring for compliance with the good laboratory practice regulations (GLPs) is to initially review 10% of the data and, if errors are found, to increase the percentage of data reviewed. However, the choice for a particular percentage of the population to be reviewed should depend upon the level of quality (i.e., the acceptable error rate) that is to be maintained and the size of the population. The probability of finding an error in the sample then determines the appropriate sample size to be audited. Statistically based sampling plans have been proposed in the past, but they do not address all aspects of the audit and are relatively inflexible. Presented here is a step-by-step approach to assist the quality assurance unit (QAU) in organizing the requirements of the data audit for bioassay data and in choosing the best available option. The following steps in the development of a sampling plan will be discussed: (1) 
DISCUSSION
The first step in the development of a data audit sampling plan is define, identify, and characterize the data to be audited. The FDA GLPs(1) provide a definition of raw data as follows: "Raw data means any laboratory worksheets, records, memoranda, notes, or exact copies thereof, that are the result of original observations and activities and are necessary for the reconstruction and evaluation of the report of that study." In the commentary for the revisions to the GLPs published in the September 4, 1987, Federal Register,Q) the FDA further specifies that data originally recorded by hand are the raw data and that subsequent transcriptions into an electronic format are not raw data. Our QAU has found it helpful to distinguish among records of original observations, transcribed data, mathematical or statistical manipulations of data, and the supporting documentation. Table 1 lists these four types of records and the different kinds of raw and transcribed data.
To identify the data to be audited, judgments must be made as to what records are necessary for the reconstruction of the study. Records of transcribed data, calculations, and statistics are generally important for the reconstruction of the study, but some transcribed data or supporting documentation may not be needed to reconstruct the study and would therefore not be included in the audit.
Once the data to be audited have been identified, the QAU must determine what characteristics of the data are to be evaluated. The GLPs are primarily interested in the integrity of the data. Integrity is defined as wholeness, soundness, unimpairedness, and completeness of the data.(3) Data characteristics of interest to the EPA Office of Monitoring Systems and Quality Assurance have also been published. These are accuracy, precision, completeness, representativeness, and comparability.(4) Accuracy is defined as the degree of agreement of a measurement X with an accepted reference or true value. Precision is defined as a measure of mutual agreement among individual measurements of the same property. Completeness is defined as a measure of the amount of valid data obtained from a measurement system compared to the amount that was expected to be obtained under current normal conditions. Representativeness is defined as the degree to which data accurately and precisely represents a characteristic of a population, parameter variations at a sampling point, a process condition, or an environmental condition. Comparability is defined as the confidence with which one data set can be compared to another. Whatever data characteristics the QAU chooses to use, the characteristics should reflect the fitness for use, since many contemporary definitions of quality are in terms of satisfying the end user's requirements. (5) 
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The second step in the development of a sampling plan is to determine what constitutes an error and how an error is to be categorized. An error can occur in any of the data quality characteristics that are to be evaluated. For GLP compliance, integrity is of the highest priority. If the protocol calls for certain data to be collected and the data are not available for review. then an error in integrity (i.e., completeness) has occurred. If cross-referenced data from one notebook entry to a work sheet or spectra do not agree, then an error in integrity (i.e., unimpairedness) has occurred. Discovering errors is fairly straightforward. Determining the significance of errors once discovered is much more difficult. Classifying errors by type, severity, frequency, and the ability of the study director to correct the error can help the QAU and the study director in determining the error's significance. For example, an error can be classified as a recording error, a calculation error, or a transcription or omission error. For severity, the errors in the least significant digit can be considered less severe than errors in the mid-, or highest significant digit. Severity is best measured in terms of the effects on statistics or on the biologic interpretation of the results. but this practice is more difficult and costly. The frequency of errors is the ratio of errors to either the sample size or the total population. The ability to rectify an error is also an important consideration. An unsigned notebook is a less significant error than a missing clinical signs record or a lost animal body weight.
The third step in the development of a sampling plan is to determine the frequency for any particular kind of error that is considered acceptable. The acceptable error rate is a measure of the desired standard of quality with respect to the end use of the data. Because standards of quality are not well defined even in a qualitative sense for bioassay data, acceptable error rates are often not available to the QA auditor. Without a well-defined qualitative or quantitative standard for data quality, it is extremely difficult for the QAU to determine the impact of various kinds of errors on data quality. Generally no errors are acceptable in the critical data, but minor documentation errors may be seen as having little effect on the fitness of use of the final results. The whole question of acceptable error rates deserves considerably more attention than it has received in the past, however, especially for those variables that fall between the most critical and the very minor.
Acceptable error rates are also needed if the QAU chooses to perform a statistically based sampling of the data. Statistically based audits (SBA) use sampling plans like the MIL-STD-IOSD(6) to accept or reject data based upon the number of errors found in a specified sample size. MIL-STD-1OSD was originally developed by the U S . Defense Department to monitor the quality of weapons produced during World War 11. It is most often used today in manufacturing industries to determine the acceptability of products from an assembly line or other relatively consistent manufacturing process. Auditors who have used SBA cite an acceptable error rate of 1.0% for bioassay data, following a general guideline from the FDA. In some cases, an acceptable error rate as low as 0.4?'0(~) has been suggested. Often, the cost for quality assurance and quality control or the cost of repeating a study are presented as determining factors for the acceptable error rates and the use of SBA. Very few, if any. QA units use quantitative methods to determine the effects of errors on the fitness for use of the data. Advocates of statistically based audits, however, argue that the relatively unstructured and arbitrary review of the data that many QAU auditors use provides no information on the likelihood of accepting bad data and is not useful for monitoring data quality over time in a sound and consistent manner. Other advantages of the SBA approach include the minimization of auditor bias, the reduction in cost when auditing data that has many errors since the data would most likely be rejected early into the audit, the focus on acceptable error rates. and the development of standardized formats for data records that allow easy randomization. One of the difficulties in performing a statistically based audit is that the sampling plans do not distinguish between different kinds of errors regardless of differences in an error's effect on the study, and as mentioned earlier, acceptable eror rates may not be available. Not only may errors not be of equal importance, they may not be independent. The probability tables used to determine sample size in MIL-STD-IOSD are based upon the assumption that errors are independent. QA audits of bioassay data often uncover clusters of errors or one error that in turn causes a series of subsequent errors. And although minimizing auditor bias was earlier cited as an advantage, the ability of an experienced QA auditor to identify deficiencies in the data is often invaluable. To assist the QAU in organizing the requirements of the data audit for bioassay data and in developing a more tractable sampling strategy, a decision tree has been designed. The decision tree shown in Figure 1 draws on information gained in the first three steps in the development of a sampling plan and provides an organized procedure to determine where vital information is missing. There may, of course, be many more ways of performing an audit than those presented in Figure 1 , but surprisingly few QA auditors are aware of even these options.
In large studies in which only samples of the data can be feasibly audited, the study director should provide a list to the QAU of the variables monitored in the study, the variables SAMPLING TECHNIQLJES FOR DATA AlrDITS identified as critical or noncritical. the numbor of data points pri \ariabie, all transcription steps, calculations, and statistics, and, if available. acceptable error rates. For studies with a small data set, a 100% audit may be the best approach. Even in large data sets in which. practically speaking, only a percentage of the data can be reviewed. it still may he teasible to look at 100% of the data for the critical variables and some lesser percentage for the noncritical variables. Obviously, if acceptable error rates cannot be determined then an SBA following MIL-STD-1OSD or some comparable standard cannot be used. In the absence of acceptable error rates most QA auditors attempt to identify as many errors as possible. Referring to Figure   I , the majority of the QA data audits performed today use choice B, 1OVo of the data a1 random, and choice 2 , selecting the IOYo by a relatively unstructured, arbitrary perusal of the data.
The use of the decision tree in the development of a sampling plan allows the QAU to choose between the various options and to quickly identify deficiencies in the available information needed to make each decision. Even when vital information is missing, a comprehensive rccord of the audit procedure based upon the various options available will assist the QAU in evaluating the effectiveness of various approach strategies.
CONCLUSION
What the previous discussion and the decision tree can do. it is hoped, is provide a framework for optimizing the use of the statistically based audit in which this approach is feasible and provide a more structured and well-defined audit in which an SBA is not feasible. A main advantage of using the tree is the focus on information that is very important to the performance of a comprehensive and efficient QA audit. Reiterating the process in the development of a sampling strategy, the first step is to clearly define. identify. and characterize the data to be audited. Second, a classification scheme for errors is needed that both defines the kind of error detected and specifies some measure of the severity of the error. Third, acceptable error rates are determined whenever possible. By identifying the different options available and the method used. the decision tree approach should help the QAU evaluate the effectiveriess of various strategies over time.
